CAD Products
(Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, and Dihydroorotase (CAD))
Categories
The de novo synthesis of pyrimidine nucleotides is required for mammalian cells to proliferate. This gene encodes a trifunctional protein which is associated with the enzymatic activities of the first 3 enzymes in the 6-step pathway of pyrimidine biosynthesis: carbamoylphosphate synthetase (CPS II), aspartate transcarbamoylase, and dihydroorotase. This protein is regulated by the mitogen-activated protein kinase (MAPK) cascade, which indicates a direct link between activation of the MAPK cascade and de novo biosynthesis of pyrimidine nucleotides. [provided by RefSeq, Jul 2008].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured CAD Categories
CAD Antibodies
High quality antibodies with extensive validation data.
Recommended CAD Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
WB, IHC (p), FACS
Validations
- (7)
Cat. No.
ABIN655062
Quantity
400 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Rat
Application
IHC, WB, IF
Validations
- (8)
Cat. No.
ABIN7264367
Quantity
200 μL
Datasheet
Datasheet
Reactivity
Human
Application
IHC, WB, IF
Validations
- (6)
Cat. No.
ABIN6137837
Quantity
100 μL
Datasheet
Datasheet
Recommended CAD Proteins
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
Cat. No.
ABIN7122124
Quantity
50 μg
Datasheet
Datasheet
Latest Publications for our CAD products
: "Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 26, Issue 1, pp. 460-7, (2012) (PubMed).: "Phospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistance." in: Cell cycle (Georgetown, Tex.), Vol. 11, Issue 20, pp. 3810-27, (2012) (PubMed).
: "Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs." in: Auris, nasus, larynx, Vol. 30, Issue 3, pp. 219-25, (2003) (PubMed).
: "Expression of caspase-activated deoxyribonuclease (CAD) and caspase 3 (CPP32) in the hydropic cochlea of guinea pigs - second report." in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, Vol. 259, Issue 5, pp. 257-61, (2002) (PubMed).
: "Over expression of inhibitor of caspase 3 activated deoxyribonuclease in human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy in vivo." in: The Journal of urology, Vol. 166, Issue 6, pp. 2491-4, (2001) (PubMed).
: "TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB." in: Immunity, Vol. 7, Issue 6, pp. 831-6, (1998) (PubMed).
Synonyms and alternative names related to CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (Cad), carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad), 2410008J01Rik, AU018859, CAD, cb456, Cpad, si:dkey-221h15.3, wu:fc30c12, wu:fc33d01, wu:fc67g02, xcadProtein level used designations for CAD
- CAD protein
- CAD trifunctional protein
- multifunctional protein CAD
- carbamyl phosphatate synthetase 2
- carbamoylphosphate synthetase 2/aspartate transcarbamylase/dihydroorotase
- carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
- CAD protein-like
- CAD protein carbamylphosphate synthetase domain
- dihydrorotate synthase
You are here:
